These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 24151743)
1. Surgical treatment of advanced ovarian cancer. David L; Dinu I; Vatachki G; Lungu V; Toader C; Popescu I Khirurgiia (Sofiia); 2013; (2):4-11. PubMed ID: 24151743 [TBL] [Abstract][Full Text] [Related]
2. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771 [TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354 [TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience. Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887 [TBL] [Abstract][Full Text] [Related]
6. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142 [TBL] [Abstract][Full Text] [Related]
7. Secondary surgical cytoreduction for advanced ovarian carcinoma. Rose PG; Nerenstone S; Brady MF; Clarke-Pearson D; Olt G; Rubin SC; Moore DH; Small JM; N Engl J Med; 2004 Dec; 351(24):2489-97. PubMed ID: 15590951 [TBL] [Abstract][Full Text] [Related]
8. [Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer]. Plaisant N; Quenet F; Fabbro M; Gourgou S; Gutowski M; Saint-Aubert B; Rouanet P Gynecol Obstet Fertil; 2004 May; 32(5):391-7. PubMed ID: 15177208 [TBL] [Abstract][Full Text] [Related]
9. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer. Chang SJ; Bristow RE; Ryu HS Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983 [TBL] [Abstract][Full Text] [Related]
10. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas]. Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068 [TBL] [Abstract][Full Text] [Related]
11. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134 [TBL] [Abstract][Full Text] [Related]
12. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864 [TBL] [Abstract][Full Text] [Related]
13. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy. Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193 [TBL] [Abstract][Full Text] [Related]
14. The integrated treatment of peritoneal carcinomatosis. A preliminary experience. Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701 [TBL] [Abstract][Full Text] [Related]
15. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
16. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
18. [Impacts of chemotherapy on long-term survival of patients with advanced epithelial ovarian cancer]. Zang R; Cai S; Zhang Z Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):738-41. PubMed ID: 16136895 [TBL] [Abstract][Full Text] [Related]
19. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer. Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622 [TBL] [Abstract][Full Text] [Related]
20. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]